Ilicicolin H
Ilicicolin H is a selective and non-ATP-competitive phosphoglycerate kinase 1 (PGK1) (IC50 = 9.02 μM) and mitochondrial cytochrome bc1 reductase (IC50 = 2-3 ng/mL) inhibitor. Ilicicolin H directly binds to PGK1 with KD of 60 μM .Ilicicolin H can inhibit cell proliferation and induce apoptosis. Ilicicolin H can inhibit the lactate production and glucose uptake of hepatocellular carcinoma (HCC) cells. Ilicicolin H has a broad antifungal spectrum including C. albicans, Cryptococcus and A. fumigatus. Ilicicolin H can be used for the researches of cancer and infection, such as hepatocellular carcinoma (HCC) and C. albicans infection[1][2].
Product Specifications
CAS Number
12689-26-8
UNSPSC
12352005
Hazard Statement
H335
Target
Apoptosis; Fungal; Phosphoglycerate Kinase (PGK)
Related Pathways
Anti-infection; Apoptosis; Metabolic Enzyme/Protease
Field of Research
Cancer; Infection
Smiles
O=C1C(C([C@H]2[C@H](/C=C/C)[C@@]3([H])C[C@@H](C)CC[C@]3([H])C(C)=C2)=O)=C(O)C(C4=CC=C(O)C=C4)=CN1
Molecular Formula
C27H31NO4
Molecular Weight
433.54
Precautions
P261-P271-P304+P340-P403+P233-P405-P501
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
PGK1
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
MEF2A (Myocyte Enhancer Factor 2A, ADCAD1, RSRFC4, RSRFC9) (APC)
MEF2A (Myocyte Enhancer Factor 2A, ADCAD1, RSRFC4, RSRFC9) (APC)
OR4K15 sgRNA CRISPR Lentivector (Human) (Target 2)